Camp4 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	49.32	64.04	38.38	83.19
Cash & Short-Term Investments	49.32	64.04	38.38	83.19
Cash Growth	28.51%	66.86%	-53.86%	-
Other Receivables	0.11	0.11	0.44	0.68
Receivables	0.11	0.11	0.44	0.68
Prepaid Expenses	0.82	0.93	0.36	0.16
Other Current Assets	1.43	1.31	0.83	0.38
Total Current Assets	51.68	66.38	40.01	84.41
Property, Plant & Equipment	9.47	10.3	13.31	16.79
Other Long-Term Assets	1.62	1.62	1.62	1.35
Total Assets	62.77	78.31	54.95	102.55
Accounts Payable	1.4	1.21	1.04	2.15
Accrued Expenses	1.84	4.3	3.01	3.17
Current Portion of Long-Term Debt	0.09	0.09	0.41	-
Current Portion of Leases	3.11	3.09	3.06	2.37
Current Unearned Revenue	-	0.39	-	-
Other Current Liabilities	-	0.54	0.29	0.26
Total Current Liabilities	6.44	9.6	7.81	7.95
Long-Term Debt	-	-	0.09	-
Long-Term Leases	4.76	5.56	8.64	10.03
Other Long-Term Liabilities	0	0	0	-0.04
Total Liabilities	11.2	15.16	16.53	17.93
Common Stock	0	0	0	0
Additional Paid-In Capital	275.76	274.9	36.23	33.14
Retained Earnings	-224.19	-211.75	-159.96	-110.67
Total Common Equity	51.57	63.14	-123.73	-77.53
Shareholders' Equity	51.57	63.14	38.42	84.62
Total Liabilities & Equity	62.77	78.31	54.95	102.55
Total Debt	7.96	8.73	12.18	12.4
Net Cash (Debt)	41.36	55.31	26.2	70.8
Net Cash Growth	57.88%	111.12%	-63.00%	-
Net Cash Per Share	4.30	11.79	66.33	226.69
Filing Date Shares Outstanding	20.16	20.15	0.46	0.31
Total Common Shares Outstanding	20.16	20.15	0.46	0.31
Working Capital	45.23	56.79	32.21	76.46
Book Value Per Share	2.56	3.13	-268.57	-248.26
Tangible Book Value	51.57	63.14	-123.73	-77.53
Tangible Book Value Per Share	2.56	3.13	-268.57	-248.26
Machinery	5.76	5.57	4.78	4.17
Leasehold Improvements	4.52	4.52	4.52	4.52

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q